CG
EVFM

Cutler Group’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Cutler Group’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,260
Closed -$1K – 6050
2022
Q1 		$1K Sell
1,260
-467
-27% -$2.94K ﹤0.01% 5197
2021
Q4 		$2K Sell
1,727
-313
-15% -$2.66K ﹤0.01% 4899
2021
Q3 		$5K Buy
2,040
+707
+53% +$8.88K ﹤0.01% 4532
2021
Q2 		$6K Buy
+1,333
New +$25.3K ﹤0.01% 4384

Other funds holding EVFM

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Cutler Group's EVFM Position: Q3 2022 in Review

Cutler Group sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 1,476 shares — an estimated $1K sold.

Cutler Group first reported a position in EVFM in Q2 2020 and held it in 8 quarters. The position peaked at $25K in Q2 2021. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

  • Cutler Group reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 1,476 Evofem Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • Cutler Group first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
  • Cutler Group's Evofem Biosciences, Inc. Common Stock position peaked at $25K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.